This topic contains a solution. Click here to go to the answer

Author Question: A volume of 390 mL is started at 7:09 a.m. at a rate of 35 mL/hr. Calculate the infusion time and ... (Read 244 times)

WWatsford

  • Hero Member
  • *****
  • Posts: 539
    • Biology Forums!
A volume of 390 mL is started at 7:09 a.m. at a rate of 35 mL/hr. Calculate the infusion time and the completion time.
 
  What will be an ideal response?

Question 2

The abbreviation for left eye is ___________.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

allisonblackmore

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

11.1 hours; 6:15 p.m.
11 hours 6 minutes; 6:15 p.m.

Infusion time is 11.1 hours, or 11 hours 6 minutes.
Completion time is 6:15 p.m.

Answer to Question 2

os




WWatsford

  • Member
  • Posts: 539
Reply 2 on: Jul 3, 2018
Thanks for the timely response, appreciate it


nanny

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library